Skip to main content

Kontrazeption und Familienplanung

  • Chapter
Die Gynäkologie

Zusammenfassung

Die Möglichkeit, den Eintritt einer Schwangerschaft zeitlich zu bestimmen bzw. die Konzeptionsmöglichkeit zu regulieren, ist sicherlich eine der wesentlichsten gesellschaftlichen Entwicklungen des 20. Jahrhunderts gewesen. Kaum eine andere Entwicklung wird gesellschaftliche Strukturen und soziale Verhaltensweisen mehr beeinflusst haben. Die Altersstruktur der deutschen Bevölkerung veranschaulicht ◘Abb. 13.1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • AG Hormone des BVF (2006) Empfehlungen zur Notfallkontrazeption mit Levonorgestrel für Ärzte im Notdienst. Frauenarzt 47 12: 1093–93

    Google Scholar 

  • Anonymous (2000) Hormonbedingtes Mammakarzinom-Wachstum. Sind die Gestagene das Problem? Gyne Z Frauenarzt 3: 72

    Google Scholar 

  • Beerthuizen R, van Beek A, Massai R, Mäkäräinen L, in't Hout J, Coelingh- Bennink HJ (2000) Bone mineral density during longterm use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod 15: 118–122

    Article  PubMed  CAS  Google Scholar 

  • Birkhäuser M, Braendle W, Kellet PJ et al. (2006) Krebsrisiko und Dosisreduktion bei Ovulationshemmern. Frauenarzt 47 12: 1105–1108

    Google Scholar 

  • Bishop E, Nelms WF (1930): A simple method of tubal sterilization. NY State J Med 39: 214

    Google Scholar 

  • Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP (2000) Higher risk of venous thrombosis during early use of oral contraceptives on woman with inherited clotting defects. Arch Intern Med 160: 49–52

    Article  PubMed  CAS  Google Scholar 

  • Chiafferino F, Parazzi F, La Vecchacia C (1999) Use of oral contraceptives and intrauterine fibroids from a case control study. Brit J Obstet Gynecol 106: 857–860

    Article  Google Scholar 

  • Croxatto HB, Mäkäräinen L (1998) Pharmakodynamik und Wirksamkeit von Implanon. Contaception 58: 91S–97S

    Article  CAS  Google Scholar 

  • Croxatto HB, Urbancsek J, Massai R, Coelingh BH, van Beek A (1999) A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod 14: 976–981

    Article  PubMed  CAS  Google Scholar 

  • Dorn C, Hugo U, Grave C (2009) Kontrazeption – individuelle Anpassung, XXI. Intensivkurs Gynäkologische Endokrinilogie und Reproduktionsmedizin, UK-SH Schleswig-Holstein/Endokrinologikum, Hamburg

    Google Scholar 

  • Dramusic V, Goh VH, Rajan U et al. (1997) Clinical, endocrinologic and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents. J Pediatr Adolesc Gynecol 10: 125–132

    PubMed  CAS  Google Scholar 

  • Dunson DB, Baird DD, Wilcox AJ, Weinberg CR (1999) Day-specific probabilities of clinical pregnancy based on two studies with imperfect measures of ovulation. Hum Reprod 14: 1835–1839

    Article  PubMed  CAS  Google Scholar 

  • Ellertson C (2000) Contraceptive choice. In: Glasier A, Gebbie AE (eds) Handbook of family planning and reproductive healthcare. Churchill Livingstone, London

    Google Scholar 

  • Ellertson C, Evans M, Ferden S et al. (2003) Extending the time limit for starting the yuzpe regimen of emergency contraception to 120 hours. Obstet Gynecol 101: 1168–1171

    Article  PubMed  Google Scholar 

  • Farmer RDT, Lawrenson RA (1998) Oral contraceptives and venous thromboembolic disease: The findings from database studies in the United Kongdom and Germany. Am J Obstet Gynacol 179: 78–86

    Article  Google Scholar 

  • Farmer RDT, Lawrenson RA, Thompson JG, Hambleton IR (1997) Population- based study of risk of venous thromboembolism associated with varous oral contraceptives. Lancet 349: 83–88

    Article  PubMed  CAS  Google Scholar 

  • Findlay JK (1996) Future direction for research on endometrial bleeding. Human Reprod 11 (Suppl 2): 179–183

    Article  Google Scholar 

  • Franceshi S, La Vecchia C (1998) Colorectal cancer and hormone replacement therapie: unexpected finding. Eur J Cancer Prev 7: 427–438

    Article  Google Scholar 

  • Garbe E, Heinemann LAJ, Rabe T, Winkler UH (2000) Nicht-kontrazeptiver Nutzen der Pille – ein oft unbeachteter Fakt. Zentralbl Gynakol 122: 18–274

    PubMed  CAS  Google Scholar 

  • Glasier AF, Smith KB, van der Spuy ZM et al. (2003) Amenorrhea associated with contraception: an international study on acceptability. Contraception 67: 1–8

    Article  PubMed  CAS  Google Scholar 

  • Göretzlehner G, Ahrendt H-J, Brucker C (2004) Langzyklus und Langzeiteinnahme. Eine neue Form der oralen hormonalen Kontrazeption? Frauenarzt 45: 199–203

    Google Scholar 

  • Göretzlehner G, Lauritzen Ch, Göretzlehner U (2007) Praktische Hormontherapie in der Gynäkologie. Berlin: De Gruyter

    Book  Google Scholar 

  • Grigorieva V, Chen-Mok M, Turasova M et al. (2003) Use of a levonorgestrel- releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 79: 1194–1198

    Article  PubMed  Google Scholar 

  • Grimes DA (2000) Intrauterine device and upper-genital-tract infection. Lancet 356: 1013–1019

    Article  PubMed  CAS  Google Scholar 

  • Gruber DM, Huber JC, Melis GB, Stagg C, Parke S, Marr J (2006) A comparison of the cycle control, safety, and efficacy profile of a 21- day regimen of ethinylestradiol 20 mug and drospirenone 3 mg with a 21-day regimen of ethinylestradiol 20 mug and desogestrel 150 mug. Treat Endocrinol. 5 (2): 115–121 [PubMed PMID: 16542051]

    Google Scholar 

  • Haberlandt L (1924) Über hormonale Sterilisierung weiblicher Tiere. II. Mitteilung (Injectionsversuche mit Corpus-Luteum, Ovarialund Placentaopton). Pflügers Arch Gesamte Physiol 200: 1–13

    Article  Google Scholar 

  • Halstrick C (2005) Juristische Aspekte der Mädchensprechstunde: Verordnung von Kontrazeptiva, Frauenarzt 46: 660–663

    Google Scholar 

  • Kadir RA, Lukas AS, Kouides PA et al. (2005) Management of excessive bleeding in women with haemostatic disorders. Fertil Steril 84: 1352–1359

    Article  PubMed  Google Scholar 

  • Kay CR (1984) Royal College of General Practitioner's oral contraception study. Clin Obstet Gynecol 11: 1018–1022

    Google Scholar 

  • Khader YS, Rice J, John L et al. (2003) Oral contraceptives and the risc of myocardial infarction: a meta-analysis. Contraception 68: 11–17

    Article  PubMed  CAS  Google Scholar 

  • Kingman CEC, Kadir RA, Lee CA et al. (2004) The use of levonorgestrelreleasing intrauterine-system for treatment of menorrhagia in women with inhelited bleeding disorders. Int J Obstet Gynecol 11: 1425–1428

    Google Scholar 

  • Kirkmann RE, Elstein NL (1998): Contraception with medroxyprogesterone may be beneficial. BMJ 316: 935

    Google Scholar 

  • Klipping CH, Duijkers I, Trummer D, Marr J (2008) Supression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 76: (1): 102–107

    Google Scholar 

  • Lätheenmäki P, Haukkamaa M, Puolakka J et al. (1998) Open randomized study of the use of levonorgestrel-releasing intrauterinesystem as alternative to hysterectomy. BMJ 316: 1122–1126

    Article  Google Scholar 

  • Lidegaard O, Kreiner S (2002) Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception 65: 197–205

    Article  PubMed  CAS  Google Scholar 

  • Marchbanks PA, McDonald JA, Wilson HG et al. (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med 346: 2025–2032

    Article  PubMed  CAS  Google Scholar 

  • McKeage K, Croxtall JD (2011) Ulipristal acetate: a review of its use in emergency contraception. Drugs 71 (7): 935–945 [PubMed PMID: 21568368]

    Google Scholar 

  • Mline RL, Knight JA, John EM et al. (2005) Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and RCA2 mutations. Cancer Epidemiol Biomarkers Prev 14: 350–356

    Article  Google Scholar 

  • Neumann F, Düsterberg B (1998) Entwicklung auf dem Gebiet der Gestagene. Reproduktionsmedizin 14: 257–264

    Article  Google Scholar 

  • Park BK, Kitteringham NR, Pirmohamed M, Tucker GT (1996) Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications, Br J Pharmacol 41: 477–491

    CAS  Google Scholar 

  • Peterson HB, Jeng G, Folger SG, Hillis SA, Marchbanks PA, Wilcox LS (2000) The risk of menstrual abnormalities after tubal sterilization. N Engl J Med 343: 1681–1687

    Article  PubMed  CAS  Google Scholar 

  • Piaggio G, von Hertzen H, Grimes DA, et al. (1999) Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task force on postovulatory methods of fertility regulation (letter). Lancet 353: 721

    Google Scholar 

  • Rizk DE, Kumar RM (1996) Congenital afibrinogenemia: treatment of excessive menstrual bleeding with continuos oral contraceptive. Am J Hematol 52: 237–238

    Article  PubMed  CAS  Google Scholar 

  • Rogoskaya S, Rivera R, Grimes DA et al. (2005) Effect of levonorgestrel- intrauterine system in women with type 1 diabetes: a randomized trial. Obstet Gynecol 105: 811–815

    Article  Google Scholar 

  • Roumen FJME, Apter D, Mulders TMT, Dieben TOM (2001) Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod 16: 469–475

    Article  PubMed  CAS  Google Scholar 

  • Schaedel ZE, Dohen G, Powell MC (2005) The use of the levonorgestrel- releasing intrauterine-system in the management of menorrhagia in women with hemostatic disorders. Am J Obstet Gynecol 193: 1361–1363

    Article  PubMed  CAS  Google Scholar 

  • Schindler AE (2001) Die Bedeutung der Gestagene bei gut- und bösartigen Brusterkrankungen. Gynäkol Praxis 25: 35–44

    Google Scholar 

  • Schindler AE (2007) Nichtkontrazeptive Anwendungsmöglichkeiten von hormonellen Kontrazeptiva. Frauenarzt 48, 7: 668–673

    Google Scholar 

  • Schlesselman JJ (1991) Oral contraceptives and neoplasia of the uterine corpus. Contraception 43: 557–579

    Article  PubMed  CAS  Google Scholar 

  • Schlesselman JJ (1995) Net effect of oral contraceptive use on the risk of cancer in women in the United States. Obstet Gynecol 85: 793–801

    Article  PubMed  CAS  Google Scholar 

  • Sillem M, Schneidereit R, Teichmann AT et al. (2003) Anwendung Drospirenon- haltigen Kontrazeptivums im Langzyklus. Frauenarzt 44: 876–881

    Google Scholar 

  • Silvera SA, MillerAB, Rohan TE (2002) Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obsts Gynecol 186: 195–197

    Article  Google Scholar 

  • Silvera SA, Miller AB, Rohan TE (2005) Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study. Cancer Causes Control 16 (9): 1059–1563 [PubMed PMID: 16184471]

    Google Scholar 

  • Spitzer WO (1996) The future or oral contraceptives: research priorities. Hum Reprod 11: 688–689

    Article  PubMed  CAS  Google Scholar 

  • Spitzer WO, Faith JM, MacRae KD (2002) Myocardial infarction and third generation oral contraceptives: aggregation of recent studies. Human Repruduction 17 (9): 2307–2314

    Article  Google Scholar 

  • Staupe G, Vieth L (1996) Die Pille – von der Lust und von der Liebe. Berlin: Rowohlt

    Google Scholar 

  • Suissa S, Blais L, Spitzer WO, Cusson, J, Lewis M, Heinemann L (1997) First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception 56: 141–146

    Article  PubMed  CAS  Google Scholar 

  • Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ (2000) Hormone withdrawalsymptoms in ral contraceptive users. Obstet Gynecol 95: 261–266

    Article  PubMed  CAS  Google Scholar 

  • Teichmann AT (1997) Empfängnisverhütung. Stuttgart New York: Thieme

    Google Scholar 

  • Timmer CJ, Mulders TMT (2000) Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet 39: 233–242

    Article  PubMed  CAS  Google Scholar 

  • Silvera SA, Miller AB, Rohan TE (2005) Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study. Cancer Causes Control 16 (9): 1059–1563 [PubMed PMID: 16184471]

    Google Scholar 

  • Vasilakis C, Jick H, del Mar Melero-Montes M (1999) Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet 354 (9190): 1610–1611 [PubMed PMID: 10560680]

    Google Scholar 

  • Vasilakis C, Jick H, del Mar Melero-Montes M (1999) Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet 354 (9190): 1610–1611 [PubMed PMID: 10560680]

    Google Scholar 

  • Von Hertzen H, Piaggio G, Van Look PF (1998) Task force on postovulatory methods of fertility regulation. Lancet 12; 352 (9144): 1939

    Google Scholar 

  • Wallwiener et al. (Hrsg) (2008) Atlas der gynäkologischen Operationen, 7. Auf. [begründet von Hirsch HA, Käser O, Iklé FA (Hrsg)]. Stuttgart New York: Thieme

    Google Scholar 

  • WHO (1998a) The World Health Organization Multinational Study of Breast-feeding and Lactational Amenorrhea. II. Factors associated with the length of amenorrhea. World Health Organization Task Force on Methods for the Natural Regulation of Fertility. Fertil Steril 70: 461471

    Google Scholar 

  • WHO (1998b) The World Health Organization Multinational Study of Breast-feeding and Lactational Amenorrhea. I. Description of infant feeding patterns and of the return of menses. World Health Organization Task Force on Methods for the Natural Regulation of Fertility. Fertil Steril 70: 448–460

    Google Scholar 

  • WHO (1999) The World Health Organization multinational study of breastfeeding and lactational amenorrhea. III. Pregnancy during breast-feeding. World Health Organization Task Force on Methods for the Natural Regulation of Fertility. Fertil Steril 72: 431– 440

    Google Scholar 

  • Wiegratz I, Hommel HH, Zimmermann T, Kuhl H (2004) Attitude of German women and gynecologists toward long-cycle treatment with oral contraceptives. Contraception 69: 37–42

    Google Scholar 

  • Wilson EW (1996) Sterilization. Baillere's Clin Obstet Gynaecol 10 (1): 103

    Article  CAS  Google Scholar 

  • Winkler UH, Schindler AE, Brinkmann OS et al. (2001) Cyclic progestin- therapy for the management of mastopathy on mastodynia. Gynecol Endocrinol 15 (Suppl 6): 637–643

    Google Scholar 

Internetadressen

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Amari, F., Beyer, D.A., Ludwig, M., Felberbaum, R.E., Weiss, J.M., Diedrich, K. (2013). Kontrazeption und Familienplanung. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20923-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-20923-9_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-20922-2

  • Online ISBN: 978-3-642-20923-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics